Skip to content

Product quality, services, and therapies for people, as well as responsible corporate action, will continue to be the basis for sustainability at Fresenius in the future. The path to a sustainable future is a long journey to which we also want to make our contribution.

Image Desc.
Image Desc.
Image Desc.

What was our starting point?

Where do we want to go?

In 1912, Dr. Eduard Fresenius started his business with a clear vision: to maintain and improve people’s health.

Improving the quality of life of ill people and promoting health has been our driving force for more than 100 years. As a healthcare group with more than 300,000 employees, Fresenius plays an important role in today’s society. With innovative solutions and forward-looking action, we provide access to high-quality and affordable medicine to a growing number of people. Responsible and sustainable corporate governance is part of our corporate culture and our day-to-day business.

An exciting affair

Sustainability will play an even more important role in our company in the future. We are focusing on developments that are closely linked to our core business, and helping to care for people around the world with our products, services and therapies.

How many infusion and nutrition pumps from Fresenius Kabi are in use worldwide?

?

200,000

Sorry – incorrect

?

700,000

Sorry – incorrect

?

more than 1,000,000

Correct:
More than 1 million infusion and nutrition pumps from Fresenius Kabi are in use worldwide.

Image Desc.
Image Desc.
Image Desc.

Where are we today?

We are on the way

We have a clear picture of where we stand in terms of sustainability and where we want our journey to take us. Orienting ourselves to our values, which have made us successful so far, will continue to be a key factor for the long-term development of our Group.

The route of travel

In recent years, we started with an assessment of existing sustainability approaches at the Group level. Building on this, we have created governance structures and resources to strengthen the integration of sustainability in the Group and to develop Group-wide targets. This sets the route for the near future.

  • Since 2016, the wide range of activities and their operational implementation across the Group have been assisted centrally .
  • The Group's annual sustainability reporting has been carried out in a separate report since 2017 and is supplemented by online content.
  • The Group Sustainability Board was established in 2020. It pursues the overarching goal of strengthening the key sustainability topics for the Group and expanding cross-Group collaboration.
  • Since 2021, the key sustainability topics have been included in the compensation of the Board of Management.
Image Desc.
Image Desc.

Making achievements visible and measurable

Moving toward the goal

It is our ambition to make sustainability visible as well to the outside. Our journey should be transparent and comprehensible.

We want to make our approaches more measurable, in all the topics that are important to us. Success in the evaluation of our company is not enough for us. However, they are proof that the path we have taken is the right one. We have improved our ESG Ratings. This reinforces our conviction that the approaches we are taking are on target.

We continue to go further

We have begun our journey on the path of sustainability. We are guided on this path by what has made us successful: Our aspiration to provide access to affordable healthcare for as many people as possible worldwide.

Ever better medicine for ever more people. A lot has happened, and our journey continues. Join us as we continue our mission!

How will the journey continue?

When does Fresenius aim to be climate neutral in terms of Scope 1 and Scope 2 emissions?

?

2030

Sorry – incorrect

?

2040

Correct:
In terms of Scope 1 and Scope 2 emissions, Fresenius plans to be climate neutral by 2040!

?

2050

Sorry – incorrect

Image Desc.
Image Desc.
Image Desc.

What’s next?

One step after the other

In our company, decisions are made that affect human lives. We carry this responsibility into all areas of Fresenius and ensure that we live up to it in the long term. For us, this means bringing a passion for research, vision and boldness to the development of products and applications that can improve people’s quality of life and sustain lives.

We follow our path in proportionate steps, always keeping our principles in mind:

  • We improve access to affordable healthcare worldwide.
  • We offer high-quality products, services, and therapies. This is crucial for top medical care.
  • We invest in innovations for better medical treatment of critically and chronically ill patients.
  • We aim to be an attractive employer. We promote diversity, commitment and personal development.
  • We protect the environment and use natural resources carefully.
  • We grow profitably and manage our company with commercial prudence.

photo credits: © Westend61 – http://stock.adobe.com , © Ali Kazal, © Stephen Meyers, ©Karsten Würth

Contact

Fresenius SE & Co. KGaA
Investor Relations & Sustainability
+49 (0) 6172 608-2485
sustainability@fresenius.com